Current Appointments & Affiliations
Associate Professor of Urology
·
2025 - Present
Urology,
Clinical Science Departments
Associate Professor in Population Health Sciences
·
2025 - Present
Population Health Sciences,
Basic Science Departments
Member in the Duke Clinical Research Institute
·
2019 - Present
Duke Clinical Research Institute,
Institutes and Centers
Member of the Duke Cancer Institute
·
2019 - Present
Duke Cancer Institute,
Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Institutes and Centers
Recent Publications
Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United States.
Journal Article Health Policy Open · June 2026 BACKGROUND: Price transparency has been cited as a tool to reduce out-of-pocket (OOP) payments to patients. These tools for prescription drugs often focus on the price to patients for the drug alone. However, costs associated with drug delivery (i.e. infus ... Full text Link to item CiteSystemic treatments for advanced prostate cancer: relationship between health insurance plan and treatment costs.
Journal Article Am J Manag Care · September 1, 2024 OBJECTIVES: The high costs of cancer care can cause significant harm to patients and society. Prostate cancer, the leading nonskin malignancy in men, is responsible for the second-highest out-of-pocket (OOP) payments among all malignancies. Multiple first- ... Full text Link to item CiteMedication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer.
Journal Article JCO Oncol Pract · April 2023 PURPOSE: The implications of high prices for cancer drugs on health care costs and patients' financial burdens are a growing concern. Patients with metastatic castrate-resistant prostate cancer (mCRPC) are often candidates for multiple first-line systemic ... Full text Link to item CiteRecent Grants
Improving outcomes of patients with advanced prostate cancer through a better understanding of provider decision-making
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027Decreasing the Financial Burden for Patients with Advanced Prostate Cancer By Understanding Provider Decision-Making
ResearchPrincipal Investigator · Awarded by American Urological Association Foundation · 2021 - 2022Disparities in the Use of Oral Anticancer Agents in Kidney Cancer
ResearchCollaborator · Awarded by National Institutes of Health · 2019 - 2020View All Grants
Education
University of Michigan, Ann Arbor ·
2017
M.S.
Medical College of Wisconsin ·
2010
M.D.
Washington University in St. Louis ·
2002
B.A.